The AlfaSight 9000TM is a state-of-the-art health testing system that identifies physiological dysfunction very early in the disease process. Using a subtle thermal stress stimulus that initiates a regulation response, underlying disturbances and dysfunctional organ systems are revealed with a high degree of accuracy.
This Whole-Body Thermometry System employs the science of Regulation Thermography, and benefits from more than 30,000 patient tests performed with a previous iteration of this technology over the past 2 decades. Disease signatures have been derived from the data and correlated with nuclear-CT (SPECT) and MRI studies that were performed by Dr. David Hickey, Radiologist and Alfa Medical Board member, in his Dallas-based imaging center.
Information provided by the AlfaSight System allows physicians to make more accurate and real-time assessments of the root cause of a disease and accompanying factors. More focused laboratory or imaging tests can then be prescribed for a more efficient and cost-effective approach to diagnosis.
The system also recognizes trends in the body that can assist in the practice of preventive medicine.
Specific areas of physiological dysfunction that can be identified include:
- Abnormalities of the female breast
- Peripheral vascular disease
- Musculoskeletal disorders
- Extracranial cerebral and facial vascular disease
- Abnormalities of the thyroid gland
- Various neoplastic and inflammatory conditions
Parallel disease factors accompanying many conditions such as heart disease, diabetes, cognitive disorders and viral diseases are also identified. Early stage detection of these factors is critical for effective treatment and faster recoveries.
The AlfaSight 9000TM is an adjunct diagnostic device and further clinical tests must be performed to determine diagnosis.
For more detailed product information, please contact us.